Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.

Capati VC, Kesselheim AS

DOI: 10.18553/jmcp.2016.22.4.339
Published: 2016 Apr
Container: Journal of managed care & specialty pharmacy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2016.22.4.339,
  title = {Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.},
  author = {Capati VC and Kesselheim AS},
  year = {2016},
  journal = {Journal of managed care \& specialty pharmacy},
  doi = {10.18553/jmcp.2016.22.4.339},
  url = {https://doi.org/10.18553/jmcp.2016.22.4.339}
}

RIS

TY  - JOUR
TI  - Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.
AU  - Capati VC
AU  - Kesselheim AS
PY  - 2016
JO  - Journal of managed care & specialty pharmacy
DO  - 10.18553/jmcp.2016.22.4.339
UR  - https://doi.org/10.18553/jmcp.2016.22.4.339
ER  -

APA

VC, C., & AS, K. (2016). Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2016.22.4.339

Source records

pubmed · retrieved 2026-09-26T11:24:14.586Z